ArticleOncotarget2016
MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.
Li Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ArticleOncotarget2016
Li Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.